Actively Recruiting

Age: 18Years +
All Genders
NCT06324201

The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.

Led by Heart Rhythm Clinical and Research Solutions, LLC · Updated on 2025-10-31

250

Participants Needed

21

Research Sites

209 weeks

Total Duration

On this page

Sponsors

H

Heart Rhythm Clinical and Research Solutions, LLC

Lead Sponsor

B

Biosense Webster, Inc.

Collaborating Sponsor

AI-Summary

What this Trial Is About

Observational, multi-center, non-randomized, post-market study. This is a nested sub-study of the REAL AF Registry. Consecutive symptomatic drug refractory paroxysmal atrial fibrillation (PAF) patients from the registry will be screened for enrollment, prospectively or retrospectively, to this sub-study per inclusion and exclusion criteria.

CONDITIONS

Official Title

The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Symptomatic drug refractory paroxysmal atrial fibrillation (episodes end spontaneously within 7 days) and considered candidates for ablation by the investigator
  • Age 18 years or older
  • Able and willing to participate in baseline and follow-up evaluations for the entire sub-study duration
  • Willing and able to provide informed consent for this sub-study
Not Eligible

You will not qualify if you...

  • Previous catheter ablation for atrial fibrillation (including PVI, roof line, or posterior wall ablation)
  • Currently enrolled in an investigational drug or device clinical trial or any trial that dictates treatment
  • Persistent or long-standing persistent atrial fibrillation
  • Any known contraindication to an ablation procedure as determined by the investigator

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 21 locations

1

Arrhythmia Institute at Grandview

Birmingham, Alabama, United States, 35209

Actively Recruiting

2

Mobile Cardiology Associates

Mobile, Alabama, United States, 36608

Actively Recruiting

3

Community Memorial Health System

Ventura, California, United States, 93003

Actively Recruiting

4

Medical City - HCA

Aurora, Colorado, United States, 80012

Actively Recruiting

5

Naples Community Hospital

Naples, Florida, United States, 34102

Withdrawn

6

Sarasota Memorial Health

Sarasota, Florida, United States, 34239

Actively Recruiting

7

Piedmont Healthcare

Atlanta, Georgia, United States, 30309

Actively Recruiting

8

Norton Heart and Vascular Institute

Louisville, Kentucky, United States, 40205

Actively Recruiting

9

The Brigham and Womens Hospital

Boston, Massachusetts, United States, 02115

Not Yet Recruiting

10

Sparrow Clinical Research Institute

Lansing, Michigan, United States, 48912

Actively Recruiting

11

Trinity Health-Michigan Heart

Ypsilanti, Michigan, United States, 48197

Actively Recruiting

12

The Christ Hospital

Cincinnati, Ohio, United States, 45219

Actively Recruiting

13

University of Cincinnati

Cincinnati, Ohio, United States, 45221

Actively Recruiting

14

University of Pennsylvania (UPENN)

Philadelphia, Pennsylvania, United States, 19104

Actively Recruiting

15

Allegheny Health

Pittsburgh, Pennsylvania, United States, 15212

Actively Recruiting

16

Centra Health, Inc.dba Stroobants Cardiovascular Center

Lynchburg, Virginia, United States, 24501

Actively Recruiting

17

Bon Secours Medical Group - Richmond Specialty Care

Richmond, Virginia, United States, 23226

Actively Recruiting

18

Valley Health System

Winchester, Virginia, United States, 22601

Actively Recruiting

19

Multicare Health Systems-Pulse Heart

Puyallup, Washington, United States, 98372

Actively Recruiting

20

Franciscan Heart and Vascular Associates

Tacoma, Washington, United States, 98401

Actively Recruiting

21

Mercy Health

Janesville, Wisconsin, United States, 53548

Actively Recruiting

Loading map...

Research Team

J

Jennifer Moss

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation. | DecenTrialz